The tumor tissue samples harvested following 4 weeks of MT-1 treatment demonstrated increased PrKD1 protein levels associated with increased substrate phosphorylation of β-catenin (T-120) and Snail (S-11) compared to tumors from mice treated with vehicle-only control (Figure 4B). This evidence concerns the gene PRKD1 and neoplasm.